|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.6 EUR | -0.71% |
|
+12.00% | +30.84% |
| Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
| Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
OSE IMMUNOTHERAPEUTICS CEO SAYS COMPANY ABLE TO PRODUCE MILLIONS OF DOSES
| 1st Jan change | Capi. | |
|---|---|---|
| +30.84% | 130M | |
| +1.12% | 43.84B | |
| +6.77% | 41.68B | |
| +45.26% | 41.25B | |
| -11.96% | 27.04B | |
| +6.01% | 25.53B | |
| -24.92% | 18.18B | |
| -3.63% | 12.29B | |
| +27.16% | 12.29B | |
| +7.30% | 11.15B |
OSE IMMUNOTHERAPEUTICS 
